COMP360

Psilocybin Training for Healthcare Providers

InnerTrek has been featured In

Compass Pathways is developing COMP360, an investigational psilocybin treatment for treatment-resistant depression.

InnerTrek is exploring potential healthcare provider training related to COMP360 care following FDA approval.

We have not yet determined what training InnerTrek may offer, who would be eligible, or when it might be available.